medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2011, Número 4

<< Anterior Siguiente >>

Arch Neurocien 2011; 16 (4)


Vagotomía y respuesta inmune

de la Cruz-Aguilera DL, Calleja J, Rangel E, Morales-Espinoza G, Aguirre-Cruz L

Idioma: Español
Referencias bibliográficas: 74
Paginas: 209-215
Archivo PDF: 126.46 Kb.


RESUMEN

Sabemos que el sistema inmune es la primera línea de defensa contra patógenos invasores, por lo que su funcionamiento apropiado es primordial para la vida. Asimismo, el sistema nervioso central interactúa con el sistema inmune para modular la inflamación a través de vías humorales y neuronales. En esta investigación se presentan los hallazgos recientes sobre la interacción del sistema nervioso e inmune, la descripción de la vía colinérgica anti-inflamatoria y las perspectivas clínicas de su conocimiento, los efectos de la vagotomía en humanos y animales, su uso terapéutico en medicina y sus perspectivas como modelo para el estudio de la respuesta colinérgica anti-inflamatoria.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Besedovsky H, Sorkin E, Keller M, Müller J. Changes in blood hormone levels during the immune response. Proc Soc Exp Biol Med 1975; 150(2): 466-70.

  2. Steinman L. Elaborate interactions between the immune and nervous systems. Nature Immunology 2004; 5(6): 575-81.

  3. Koj A. Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta 1996; 1317(2):84-94.

  4. Oke SL, Tracey KJ. The inflammatory reflex and the role of complementary and alternative medical therapies. Ann N Y Acad Sci 2009; 1172:172-80.

  5. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, et al. Shock and tissue injury induced by recombinant human cachectin. Science. 1986; 234(4775): 470-4.

  6. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15:74-80.

  7. Goldhammer E, Tanchilevitch A, Maor I, Beniamini Y, Rosenschein U, Sagiv M. Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 2005;100(1):93-9.

  8. Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 2007;48(4):751-62.

  9. Gross P, Weindl A. Peering through the windows of the brain. J Cereb Blood Flow Metab 1987;7(6):663-72.

  10. Matsumura K, Watanabe Y, Onoe H, Watanabe Y, Hayaishi O. High density of prostaglandin E2 binding sites in the anterior wall of the 3rd ventricle, a possible site of its hyperthermic action. Brain Res 1990;533(1):147-51.

  11. Johnson A, Gross P. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 1993;7(8):678-86.

  12. Plotkin S, Banks W, Kastin A. Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood-brain barrier. J Neuro-immunol 1996;67(1):41-7.

  13. Parrott RF, Bellucci SV. Effects of centrally administered prostaglandin EP receptor agonists on febrile and adrenocortical responses in the prepubertal pig. Brain Res Bull 1996;41(2):97- 103.

  14. Ericsson A, Arias C, Sawchenko P. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stressrelated neuroendocrine circuitry by intravenous interleukin-1. J Neurosci 1997;17(18):7166-79.

  15. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2001;26:761-88.

  16. Webster J, Tonelli L, Sternberg E. Neuroendocrine regulation of immunity. Annu Rev Immunol 2002;20:125-62.

  17. Johnston GR, Webster NR. Cytokines and the immühomodulatory function of the vagus nervé. Br J Anaésth 2009;104(4): 453-62.

  18. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 2009; 9(6):418-28.

  19. Van Der Zanden EP, Boeckxstaens GE, de Jonge WJ. The vagus nerve as a modulator of intestinal inflammation. Neurogastroenterol Motil 2009;21(1):6-17.

  20. Hansen MK, Daniels S, Goehler LE, Gaykema RP, Maier SF, Watkins LR. Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever. Auton Neurosci 2000a;85(1-3):83-7.

  21. van Westerloo DJ, Giebelen IA, Florquin S, Daalhuisen J, Bruno MJ, de Vos AF, et al. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 2005; 191(12):2138-48.

  22. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006; 131(4):1122-30.

  23. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Susarla S, Czura CJ, et al. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 2002; 36(6):1231-6.

  24. Guarini S, Altavilla D, Cainazzo MM, Giuliani D, Bigiani A, Marini H, et al. Efferent vagal fibre stimulation blunts nuclear factorkappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003;107(8):1189-94.

  25. Huston JM, Gallowitsch-Puerta M, Ochani M, Ochani K, Yuan R, Rosas-Ballina M, et al. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007;35(12):2762-8.

  26. Tracey KJ. The inflammatory reflex. Nature 2002;420(6917):853-9.

  27. Wexler BC, Dolgin AE, Tryczynski EW. Effects of bacterial polysaccharide (Piromen) on the pituitary-adrenal axis: adrenal ascorbic acid, cholesterol and histologic alterations. Endocrionol 1957;61:300-8.

  28. Maier SF, Goehler LE, Fleshner M, Watkins LR. The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci 1998; 840:289-300.

  29. Chiao H, Kohda Y, McLeroy P, Craig L, Linas S, Star RA. Alphamelanocyte- stimulating hormone inhibits renal injury in the absence of neutrophils. Kidney Int 1998;54(3):765-74.

  30. Watkins LR, Maier SF. Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci USA 1999;96(14):7710-13.

  31. Wang H, Yu M, Ochani M, Amelia CA, Tanovic M, Susaria S, et al. Nicotinic acetylcholine receptor a7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8.

  32. Cianchetti S, Del Fiorentino A, Colognato R, Di Stefano R, Franzoni F, Pedrinelli R. Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. Atherosclerosis 2008;198(1):22-8.

  33. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444-51.

  34. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, et al. A randomized, controlled trial of IL-10 in humans: inhibition of inflammatory cytokine production and immune responses. J Immunol 1995;154:5492-9.

  35. Chakraborty A, Blum RA, Mis SM, Cutler DL, Jusko WJ. Pharmacokinetic and adrenal interactions of IL-10 and prednisone in healthy volunteers. J Clin Pharmacol 1999;39:624-35.

  36. Zabel BA, Zuniga L, Ohyama T, Allen SJ, Cichy J, Handel TM, et al. Chemoattractants, extracellular proteases, and the integrated host defense response. Exp Hematol 2006;34(8):1021-32.

  37. Czura C, Rosas-Ballina M, Tracey K. Cholinergic regulation of inflammation. En: Ader R, Dantzer R, Glaser R, Heijnen C, Irwin M, Padgett D, Sheridan J (eds). Psychoneuroimmunology Elsevier 2007;(I):85-96.

  38. Gross P, Weindl A. Peering through the windows of the brain. J Cereb Blood Flow Metab 1987;7(6):663-72.

  39. Borovikova, LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405-61.

  40. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N YAcad Sci 2001;933:222-34.

  41. Pavlov VA, Tracey KJ. Neural regulators of innate immune responses and inflammation. Cell Mol Life Sci 2004;61(18):2322-31.

  42. George MS, Sackeim HA, Rush AJ, Marangell LB, Nahas Z, Husain MM, et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry 2000;47(4):287-95.

  43. Fleshner M, Goehler LE, Schwartz BA, McGorry M, Martin D, Maier SF, et al. Thermogenic and corticosterone responses to intravenous cytokines (IL-1 beta and TNF-alpha) are attenuated by subdiaphragmatic vagotomy. J Neuroimmunol 1998;86(2): 134-41.

  44. Proskocil BJ, Sekhon HS, Jia Y, Savchenko V, Blakely RD, Lindstrom J, et al. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 2004;145(5):2498-506.

  45. Saeed RW, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, Huston J, et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 2005;201(7):1113-23.

  46. De Jonge WJ, van der Zanden EP, Bijlsma MF, van Westerloo DJ, Bennink RJ, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005;6(8):844-51.

  47. Yoshikawa H, Kurokawa M, Ozaki N, Nara K, Atou K, Takada E, et al. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of 1-kappaß phosphorylation and nuclear factor-kappaß transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol 2006; 146(1): 116-23.

  48. Metz CN, Tracey KJ. It takes nerve to dampen inflammation. Nat Immunol 2005; 6(8):756-57.

  49. Dragstedt LR, Palmer WL, Schafer PW, Hodges PC. Supra-diaphragmatic section of the vagus nerves in the treatment of duodenal and gastric ulcers. Gastroenterology 1944;3:450.

  50. Amdrup E, Jensen HE. Selective vagotomy of the parietal cell mass preserving innervation of the undrained antrum. A preliminary report of results in patients with duodenal ulcer. Gastroenterology 1970;59(4):522-7.

  51. Stabile BE. Current surgical management of duodenal ulcers. Surg Clin North Am 1992;72(2):335-56.

  52. Balbo SL, Mathias PC, Bonfleur ML, Alves HF, Siroti FJ, Monteiro OG et al. Vagotomy reduces obesity in MSG-treated rats. Res Commun Mol Pathol Pharmacol 2000;108(5-6):291-6.

  53. Kral JG, Paez W, Wolfe BM. Vagal nerve function in obesity: therapeutic implications. World J Surg 2009; 33(10):1995-2006.

  54. Kral JG. Vagal mechanisms in appetite regulation. Int J Obes 1981;5(5):481-9.

  55. Laskiewicz J, Królczyk G, Zurowski G, Sobocki J, Matyja A, Thor PJ. Effects of vagal neuromodulation and vagotomy on control of food intake and body weight in rats. J Physiol Pharmacol 2003; 54(4): 603-10.

  56. Hansen MK, Nguyen KT, Fleshner M, Goehler LE, Gaykema RP, Maier SF, et al. Effects of vagotomy on serum endotoxin, cytokines, and corticosterone after intraperitoneal lipopoly-saccharide. Am J Physiol Regul Integr Comp. Physiol 2000b; 278 (2), R331-R6.

  57. Hansen MK, Nguyen KT, Goehler LE, Gaykema RP, Fleshner M, Maier SF, et al. Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1beta protein in rats. Auton. Neurosci 2000c; 85 (1-3):119-26.

  58. Milligan ED, McGorry MM, Fleshner M, Gaykema RP, Goehler LE, Watkins LR, et al. Subdiaphragmatic vagotomy does not prevent fever following intracerebroventricular prostaglandin E2: further evidence for the importance of vagal afferents in immune-tobrain communication. Brain Res 1997;766(1-2):240-3.

  59. 59 Kessler W, Traeger T, Westerholt A, Neher F, Mikulcak M, Müller A, et al. The vagal nerve as a link between the nervous and immune system in the instance of polymicrobial sepsis. Langenbecks Arch Surg 2006;391(2):83-7.

  60. van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 2006;130(6):1822-30.

  61. Rosas-Ballina M, Tracey K. Cholinergic control of inflammation. J Intern Med 2009;265:663-79.

  62. Andersson J. The immflamatory reflex-introduction. J Intern Mol 2005; 257(2):122-25.

  63. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005;6(12):1191-7.

  64. Bianchi M, Bloom O, Raabe T, Cohen PS, Chesney J, Sherry B, et al. Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med 1996;183(3):927-36.

  65. Hommes D, van den Blink B, Plasse T, Bartelsman J, Xu C, Macpherson B, et al. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn’s disease. Gastroenterology 2002;122(1):7-14.

  66. Arai I, Hirose H, Muramatsu M, Okuyama S, Aihara H. Possible involvement of non-steroidal anti-inflammatory- drugs in vagalmediated gastric acid secretion in rats. Jpn J Pharmacol 1985; 37(1):91-9.

  67. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, et al. Cholinergic agonists inhibit HMGB1 26 release and improve survival in experimental sepsis. Nat Med 2004;10(11):1216-21.

  68. Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994; 330(12):811-5.

  69. Sandborn WJ, Tremaine WJ, Offord KP, Lawson GM, Petersen BT, Batts KP, et al. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebocontrolled trial. Ann Intern Med 1997;126(5): 364-71.

  70. De Simone R, Ajmone-Cat MA, Carnevale D, Minghetti L. Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J Neuroinflammation 2005;25;2(1):4.

  71. Felson DT, Anderson JJ, Naimark A, Hannan MT, Kannel WB, Meenan RF. Does smoking protect against osteoarthritis? Arthritis Rheum. 1989; 32(2):166-72.

  72. Schmidt HB, Werdan K, Müller-Werdan U. Autonomic dysfunction in the ICU patient. Curr Opin Crit Care 2001;7(5):314-22.

  73. Barnaby D, Ferrick K, Kaplan DT, Shah S, Bijur P, Gallagher EJ. Heart rate variability in emergency department patients with sepsis. Acad Emerg Med 2002;9(7):661-70.

  74. Pontet J, Contreras P, Curbelo A, Medina J, Noveri S, Bentancourt S, et al. Heart rate variability as early marker of multiple organ dysfunction syndrome in septic patients. J Crit Care 2003;18(3):156-63.




2020     |     www.medigraphic.com